logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Werewolf Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 12


Trademarks = 3

Forward Citations = 25

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal William Winston (12 out of 20 patents)

silverMedal Daniel Hicklin (11 out of 24 patents)

bronzeMedal Cynthia Seidel-Dugan (11 out of 17 patents)

4.  Heather R Brodkin (10 out of 14 patents)

5.  Vinay Bhaskar (9 out of 39 patents)

6.  Jose Andres Salmeron Garcia (9 out of 9 patents)

7.  Luke Evnin (8 out of 24 patents)

8.  Patrick A Baeuerle (7 out of 35 patents)

9.  Jose Andres Salemeron-garcia (2 out of 2 patents)

10.  Luke Evnin (1 out of 4 patents)

11.  Giselle Knudsen (1 out of 1 patent)

12.  Daniel J Hicklin (1 out of 1 patent)

13.  Cynthia Seidel-dugan (1 out of 1 patent)

14.  Patrick Baeuerle (1 out of 1 patent)

15.  Heather Brodkin (1 out of 1 patent)


12 patents:

1. 12617829 - ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF (2026-05-05),
2. 12534505 - ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF (2026-01-27),
3. 12275769 - Activatable interleukin 12 polypeptides and methods of use thereof (2025-04-14),
4. 12076371 - Activatable cytokine polypeptides and methods of use thereof (2024-09-03),
5. 12036266 - Activatable cytokine polypeptides and methods of use thereof (2024-07-16),
6. 11981716 - Activatable interleukin-2 polypeptides and methods of use thereof (2024-05-14),
7. 11739132 - Separation moieties and methods of use thereof (2023-08-29),
8. 11535658 - Activatable interleukin-2 polypeptides and methods of use thereof (2022-12-27),
9. 11453710 - Activatable interleukin 12 polypeptides and methods of use thereof (2022-09-27),
10. 11352403 - Activatable interleukin-2 polypeptides and methods of use thereof (2022-06-07),
11. 10696724 - Activatable interleukin-2 polypeptides (2020-06-30),
12. 10696723 - Activatable interleukin 12 polypeptides (2020-06-30),
Company Overview
Werewolf Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative therapies for cancer and other serious diseases. The company specializes in its proprietary platform that enhances the delivery and efficacy of biologic drugs, aiming to improve patient outcomes through targeted treatment approaches. With a commitment to advancing therapeutic options, Werewolf Therapeutics is at the forefront of research in the biopharmaceutical sector, leveraging cutting-edge technology to address unmet medical needs.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#205 in Cambridge, MA

#1,549 in Massachusetts

#25,589 in US

#48,235 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Werewolf Therapeutics, Inc.

Forward Citations = 25

17 inventors:

goldMedal William Winston (12 out of 20 patents)

silverMedal Daniel Hicklin (11 out of 24 patents)

bronzeMedal Cynthia Seidel-Dugan (11 out of 17 patents)

4.  Heather R Brodkin (10 out of 14 patents)

5.  Vinay Bhaskar (9 out of 39 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Werewolf Therapeutics, Inc.. Retrieved from https://idiyas.com/company/werewolf-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…